Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
Epilepsy is considered as a common and diverse set of chronic neurological disorders and its symptoms can be controlled by antiepileptic drugs (AEDs). The presence of p-glycoprotein and multi-drug resistance transporters in the blood-brain barrier could prevent the entry of AEDs into the brain, caus...
Saved in:
Main Authors: | Shanshan Liu (Author), Shili Yang (Author), Paul C. Ho (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chitosan Nanoparticles for Intranasal Drug Delivery
by: Hossein Omidian, et al.
Published: (2024) -
Doxorubicin-Loaded Fungal-Carboxymethyl Chitosan Functionalized Polydopamine Nanoparticles for Photothermal Cancer Therapy
by: Maduru Suneetha, et al.
Published: (2023) -
Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery
by: Sanjeevani Shekhar Deshkar, et al.
Published: (2021) -
Novel Nanoparticles Based on <i>N</i>,<i>O</i>-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery
by: Adriana Trapani, et al.
Published: (2022) -
In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
by: Huahui Zeng, et al.
Published: (2020)